CrunchBase is hiring! Check out our open positions →
Register | Login or Login

General Information

Websitentt-inc.com
CategoryBioTech
Phone302-571-1128
Employees
Founded2003

Offices

Wilmington, USA
c/o PHS Corporate Services, Inc.
1313 Market Street, Suite 5100
Wilmington, DE, 19801
USA

People

Chairman of the Board
ounder – President & Business Affairs Director

Funding

TOTAL $75M
FUNDING TOTAL $75M
Venture Round, 12/11
Access BridgeGap Ventures
$75M

Tags

Novel Therapeutic Technologies

Novel Therapeutic Technology Inc. (NTT) is a leading pioneer in the development of sophisticated and practical drug delivery systems. NTT’s Ethosome technology provides the means to significantly enhance drug penetration of topical delivery applications, exponentially increasing therapeutic efficiency. With worldwide recognized drugs combined with NTT know-how, Pharmaceutical companies are able to introduce new and better drugs to the market, thus greatly reducing side effects, improving patient compliance, and increasing the patient’s quality of life.

Recent Milestones

Videos

Screenshots

Novel Therapeutic Technologies screenshot
Above: Home page
Uploaded: 2/14/12

Sources

  1. Access Industries To Invest $75M Through VC Arm (fis.dowjones.com) [edit]
Edit This Page
Last Edited 2/13/12

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy